1. Home
  2. EXAS vs IOT Comparison

EXAS vs IOT Comparison

Compare EXAS & IOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.38

Market Cap

19.6B

Sector

Health Care

ML Signal

HOLD

Logo Samsara Inc.

IOT

Samsara Inc.

HOLD

Current Price

$27.01

Market Cap

15.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
IOT
Founded
1995
2015
Country
Employees
N/A
N/A
Industry
Medical Specialities
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
15.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
IOT
Price
$103.38
$27.01
Analyst Decision
Buy
Buy
Analyst Count
19
12
Target Price
$84.27
$47.92
AVG Volume (30 Days)
2.4M
9.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.40
$29.12
Revenue Next Year
$13.54
$20.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.81
$23.38
52 Week High
$103.54
$61.90

Technical Indicators

Market Signals
Indicator
EXAS
IOT
Relative Strength Index (RSI) 69.20 40.01
Support Level $103.14 $25.38
Resistance Level $103.87 $28.28
Average True Range (ATR) 0.35 1.66
MACD -0.12 0.29
Stochastic Oscillator 72.08 56.03

Price Performance

Historical Comparison
EXAS
IOT

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.

Share on Social Networks: